We help communities to created a custom knowledge base(still being refined)
Click here to view original web page at Changing Treatment Can Help Multiple Sclerosis Patients
Summary: The number of relapses in patients with relapsing-remitting multiple sclerosis was better controlled and symptoms of disability were stabilized or improved when patients who discontinued fingolimod changed to either ocrelizumab or natalizumab. Source: Monash University Monash University researchers have used the world’s largest multiple sclerosis (MS) registry, MSBase, […]
Click here to view original web page at Changing Treatment Can Help Multiple Sclerosis Patients
Summary: The number of relapses in patients with relapsing-remitting multiple sclerosis was better controlled and symptoms of disability were stabilized or improved when patients who discontinued fingolimod changed to either ocrelizumab or natalizumab. Source: Monash University Monash University researchers have used the world’s largest multiple sclerosis (MS) registry, MSBase, […]
Click here to view original web page at Dozens of Gut Bacteria Associated With Multiple Sclerosis
Summary: Researchers reveal significant differences in gut bacteria in patients with multiple sclerosis compared to those without the autoimmune disease. The study also uncovered novel mechanisms by which the bacteria may influence the disease. Source: UCSF An international research consortium led by UC San Francisco scientists has shown significant […]
Click here to view original web page at Unlocking the Mystery of ”Chemo Brain”
Summary: Researchers have uncovered the molecular mechanisms behind cognitive deficits and brain fog associated with chemotherapy, and identified a current FDA-approved drug for multiple sclerosis that can help reduce chemotherapy-induced cognitive impairments. Source: St Louis University Though chemotherapy can be lifesaving, the cancer treatment often leaves patients suffering from […]
Click here to view original web page at Multiple Sclerosis Drug Works in a Surprising Way
Summary: Interferon betas, a class of drugs commonly prescribed to those with multiple sclerosis reduces the binding of zinc, C-peptide, and albumin to red blood cells. Source: ACS Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a […]
Summary: Social support and social integration help improve overall health and well-being for those with multiple sclerosis. Source: Kessler Foundation Researchers conducted a comprehensive online survey of people with multiple sclerosis, assessing their health, lifestyle, personality, MS symptomatology, psychological well-being, social support, and social integration. Study findings suggest that […]
Summary: Study reveals an association between signal detection theory, brain activation patterns, and subjective state fatigue. In those with multiple sclerosis, greater effects of fatigue were seen. Source: Kessler Foundation Using signal detection theory, Kessler Foundation researchers furthered their understanding of the mechanisms of cognitive fatigue in a recent […]
The Company’s Recent Study Results will be Presented at the AAIC 2022 Conference in San Diego, California Demonstrating how its CognICA TM Tool Can Lead to Earlier Diagnosis of Dementia and Alzheimer’s Disease and Improve Health Economics of Disease Detection VANCOUVER, BC, May 31, 2022 /CNW/ – Cognetivity Neurosciences […]
Summary: In the first year after a diagnosis of multiple sclerosis, 60% of patients experience fatigue, 50% experience pain, 47% have symptoms of depression, and 39% report increased anxiety. Researchers say urgent, non-pharmaceutical therapies should be provided for newly diagnosed MS patients to help reduce both pain and mental […]
Cumulus’ integrated platform combines multiple digital Central Nervous System (CNS) measurement tools with AI analytics The platform enables real-world, longitudinal assessments of disease progression to accelerate CNS clinical trials CNS-101 and CNS-102 studies will assess the platform in early-stage Alzheimer’s Disease (AD) dementia, Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal […]
